Skip to main navigation Skip to search Skip to main content

Letter to the Editor : Antimicrobial Photodynamic Therapy with Hypocrellin B against SARS-CoV-2 infection?

Research output: Other PublicationsOther ArticleCommunication

Abstract

Dear Editor,
We still do not have effective therapy to combat SARS-CoV-2 except vaccination. Antimicrobial photodynamic therapy (aPDT) might be a good choice for the prevention and treatment of SARS-CoV-2 because it may only target the infection area using photosensitizers with a specific wavelength. “Hypocrellin B” is a substance used traditionally in Chinese medicine and as a photosensitizer which is used in China to treat many diseases. Its photodynamic action and research progress of "hypocrellin B" will be discussed. Why do we apply PDT with "hypocrellin B" as a photosensitizer against SARS-CoV-2? Is this a possible choice for the treatment of patients with SARS-CoV-2?
Original languageEnglish
Volume34
Specialist publicationPhotodiagnosis and Photodynamic Therapy
DOIs
Publication statusPublished - Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Letter to the Editor : Antimicrobial Photodynamic Therapy with Hypocrellin B against SARS-CoV-2 infection?'. Together they form a unique fingerprint.

Cite this